Power Law company profile

Terns Pharmaceuticals

Biotech & Life Sciences · Foster City, United States · Founded 2017 · IPO 2021 Unicorn

Biopharmaceutical company focused on discovering therapies that will improve the global disease burden

Valuation

$5.10B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

8 investors on Terns Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Lilly Asia Ventures

Series B+ 7 investors entered at this stage

Deerfield

OrbiMed

Samara Capital

Vivo Capital

Decheng Capital

Suvretta Capital Management

Eli Lilly

Global footprint

Where Terns Pharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · Foster City HQ

Book a demo for the full country breakdown

Web traffic by country

14K monthly visits
across markets

🇺🇸 United States82.1%

🇬🇧 United Kingdom13.6%

🇯🇵 Japan2.1%

Top 3 markets shown

Market sentiment

What the market is saying about Terns Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Terns Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Terns Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles